A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CysLT1 / cysteinyl leukotriene receptor 1

[Related PubMed/MEDLINE]
Total Number of Papers: 23
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CysLT1  (>> Co-occurring Abbreviation)
Long Form:   cysteinyl leukotriene receptor 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A simple and sensitive HPLC-MS/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study. ---
2019 Cysteinyl leukotriene receptor antagonism: a promising pharmacological strategy for lowering the severity of arthritis. MMP
2018 Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma. LTRAs
2018 New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses. LTD4, MCTR
2017 Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain. 5-LO, CNS, cPLA2alpha, LTs
2017 Screening of Sceptridium ternatum for antitussive and antiasthmatic activity and associated mechanisms. ---
2014 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. 5-LOX, EGF, LTC4, Tiam1
2014 Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate. 5-LO, LRRC8A, RES, WT
2013 Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. cAMP, FPR2, GTPgamma, IL, LX
10  2012 Resolvins as new fascinating drug candidates for inflammatory diseases. GPR32, PMN
11  2012 The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. CLL, CysLT, GPCR
12  2010 Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats. AST, CL, I/R, LDH, MDA, MPO
13  2009 Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. DCs
14  2008 Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. NHLs, PMBCL
15  2007 A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate. CysLT2
16  2006 Montelukast protects against renal ischemia/reperfusion injury in rats. AOC, CL, I/R, LDH, MDA, MPO
17  2006 Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury. ---
18  2006 The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. ---
19  2005 Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. MCAO
20  2005 ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats. NMDA, VCAM-1
21  2005 Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. MCAO
22  2003 Benefit-risk assessment of antileukotrienes in the management of asthma. ---
23  2001 Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. HASM, IFN, LT, mRNA